Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?
about
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.Optimal management of metastatic renal cell carcinoma: current status.Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Renal cell carcinoma: new insights and challenges for a clinician scientist.Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma.
P2860
Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Non-clear cell renal cell carc ...... a rational therapeutic target?
@ast
Non-clear cell renal cell carc ...... a rational therapeutic target?
@en
type
label
Non-clear cell renal cell carc ...... a rational therapeutic target?
@ast
Non-clear cell renal cell carc ...... a rational therapeutic target?
@en
prefLabel
Non-clear cell renal cell carc ...... a rational therapeutic target?
@ast
Non-clear cell renal cell carc ...... a rational therapeutic target?
@en
P2860
P1433
P1476
Non-clear cell renal cell carc ...... a rational therapeutic target?
@en
P2093
Laurence Albiges
Vincent Molinie
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0038
P577
2012-07-17T00:00:00Z